Global Health · NSE: MEDANTA · BSE: 543654
Q1 FY24 results · Apr–Jun 2023
Global Health reported revenue from operations of ₹773.04 crore and net profit of ₹102.01 crore for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 773.04 | — | — | 703.42 | +9.9% |
| Other income | 21.46 | — | — | 28.41 | −24.5% |
| Total income | 794.50 | — | — | 731.83 | +8.6% |
| Profit before tax | 141.04 | — | — | 133.08 | +6.0% |
| Net profit for the period | 102.01 | — | — | 101.07 | +0.9% |
| EPS, basic (₹) | 3.80 | — | — | 3.77 | +0.8% |
| Net margin (%) | 13.2 | — | 14.4 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 544.59 | — | — | 502.91 | +8.3% |
| Other income | 33.20 | — | — | 28.10 | +18.1% |
| Total income | 577.79 | — | — | 531.01 | +8.8% |
| Profit before tax | 115.74 | — | — | 104.19 | +11.1% |
| Net profit for the period | 86.21 | — | — | 80.96 | +6.5% |
| EPS, basic (₹) | 3.21 | — | — | 3.02 | +6.3% |
| Net margin (%) | 15.8 | — | 16.1 |
Consolidated
- Filed with BSE
- 10 Aug 2023, 17:58 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2023, 17:58 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE